Cite

HARVARD Citation

    Juric, D. et al. (n.d.). 342 A Phase Ib/II study of alpelisib (BYL719) and ganitumab (AMG 479) in adult patients with selected advanced solid tumors. European journal of cancer. pp. S68-. [Online]. 
  
Back to record